Revolutionizing Meta-Analyses in Clinical Research
Our groundbreaking AI-powered agent automates meta-analysis studies in clinical trials and medical research. Leveraging advanced AI technologies, our solution streamlines the entire meta-analysis process, significantly reducing time and costs while enhancing accuracy and efficiency.
End-to-End Automation
Automates literature search, data extraction, statistical analysis, and report generation without human intervention.
Compliance with Best Practices
Adheres to PRISMA guidelines and promotes methodological rigor.
Cost-Effective and Scalable
Optimises LLM inference to reduce operational costs, making large-scale analyses feasible.
Customisable Analyses
Supports various statistical methods, such as NMA, to suit specific research needs.
Comparative Effectiveness Assessment
Use NMA to simultaneously compare the efficacy and safety of multiple treatments, inform clinical decision-making and guideline development.
Market Access
Leverage NMA to position new pharmaceutical products against competitors, aid pricing / market access planning and other HEOR tasks.
Clinical Trial Design Optimisation
Utilise NMA findings to select appropriate comparators and endpoints, improving the design and relevance of clinical trials.
Enhance Regulatory Submission
Include NMA into regulatory dossiers as part of HEOR strategies to provide comprehensive comparative data when direct head-to-head trials are lacking.
Clinical Practice Guidelines
Rank treatments based on efficacy and safety, assisting in the creation of evidence-based guidelines.
Partnerships and Sponsorships
